Results 241 to 250 of about 2,926,121 (366)
Embelin cotargets SHP2 to disrupt the SHP2/GRB2/SOS complex, inhibiting cancer‐related signaling pathways such as MAPK, (PI3K)/AKT pathway, and XIAP to induce apoptosis signaling pathway, respectively, leading to synthetic lethality in KRAS‐mutant NSCLC cells both in vivo and in vitro.
Nai‐jie Fu+8 more
wiley +1 more source
Network pharmacology and experimental validation of Compound Kushen Powder for the treatment of diarrhea in vivo. [PDF]
Yu B+8 more
europepmc +1 more source
The non‐conventional oleaginous yeast Y. lipolytica has been genetically engineered to produce malonic acid via malonyl‐CoA pathway through introducing an efficient malonyl‐CoA hydrolase. Advanced metabolic engineering and optimization of fermentation conditions resulted in a malonic acid production yield of 19.1 g L−1 in shaking‐flasks.
Qun Yang+4 more
wiley +1 more source
The series of newer salicylate derivatives incorporating nitroxy functionality were synthesized and evaluated for their potential effect in gastrointestinal (GI) related toxicity produced by aspirin. The synthesized compounds (5a-j) were subjected to %NO
Amruta M. Amritkar+8 more
doaj
Integration of network pharmacology and experimental validation to explore the pharmacological mechanism of andrographolide against asthma. [PDF]
Yu Q, Zhu L, Ding X, Lou Y.
europepmc +1 more source
The long non‐coding RNA (lncRNA) CD2BP2‐DT is upregulated in breast cancer and correlates with poor patient prognosis. Mechanistically, CD2BP2‐DT drives YBX1 phase separation to stabilize CDK1 and promote breast cancer progression. Moreover, NAT10‐mediated N4‐acetylcytosine (ac4C) modification further enhances CD2BP2‐DT expression.
Hongyu Wang+9 more
wiley +1 more source
Paclitaxel/Luteolin Coloaded Dual‐Functional Liposomes for Esophageal Cancer Therapy
The authors develop a pH‐sensitive aptamer‐modified liposome (EA2‐PSL‐PTX/LUT) to illustrate a strategy for the precise delivery of combinational chemotherapeutic drugs for esophageal squamous cell carcinoma (ESCC) targeted therapy. EA2‐PSL‐PTX/LUT provides efficient co‐loading, tumor targeting, and controlled release of luteolin and paclitaxel ...
Congyong Sun+9 more
wiley +1 more source
Healing progression of tail docking and ear tag wounds in lambs. [PDF]
Woods JM, Adcock SJJ.
europepmc +1 more source
Ca2+/calmodulin‐dependent kinase II (CaMKII) activation is likely driven by oxidative stress, particularly excessive reactive oxygen species (ROS) production. This study identifies P21‐activated kinase 2 (Pak2) as a novel regulator of ROS‐induced CaMKII activation and abnormal Ca2⁺ dynamics in acute adrenergic and chronic pressure‐overload stressed ...
Tao Li+21 more
wiley +1 more source
Immunoinformatics method to design universal multi-epitope nanoparticle vaccine for TGEV S protein. [PDF]
Li S, Yu J, Xiao C, Li Y.
europepmc +1 more source